CRISPR/Cas9 genome editing is used to insert a bovine growth hormone cassette and a poly adenylation sequence 70 base pairs after the transcription start site. The mutation results in premature termination of Ifngas1 transcription without disrupting the local chromatin architecture. (J:283672)